Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1943 1
1945 1
1946 3
1947 3
1948 1
1949 1
1952 1
1953 1
1986 2
1987 1
1988 1
1990 3
1991 3
1993 2
1995 1
2004 1
2015 1
2016 6
2018 1
2019 1
2020 4
2021 2
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Myelodysplastic syndromes.
Yeomans AC, Harle MT. Yeomans AC, et al. Semin Oncol Nurs. 1990 Feb;6(1):9-16. doi: 10.1016/s0749-2081(05)80128-7. Semin Oncol Nurs. 1990. PMID: 2406831 Review.
Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy.
Ciccimarra F, Luxi N, Bellitto C, L' Abbate L, De Nardo P, Savoldi A, Yeomans A, Molokhia M, Tacconelli E, Trifirò G. Ciccimarra F, et al. Among authors: yeomans a. BioDrugs. 2023 Sep;37(5):675-684. doi: 10.1007/s40259-023-00601-w. Epub 2023 May 6. BioDrugs. 2023. PMID: 37148526 Free PMC article.
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas.
Heward J, Konali L, D'Avola A, Close K, Yeomans A, Philpott M, Dunford J, Rahim T, Al Seraihi AF, Wang J, Korfi K, Araf S, Iqbal S, Bewicke-Copley F, Kumar E, Barisic D, Calaminici M, Clear A, Gribben J, Johnson P, Neve R, Cutillas P, Okosun J, Oppermann U, Melnick A, Packham G, Fitzgibbon J. Heward J, et al. Among authors: yeomans a. Blood. 2021 Aug 5;138(5):370-381. doi: 10.1182/blood.2020008743. Blood. 2021. PMID: 33786580 Free PMC article.
A ribosome-related signature in peripheral blood CLL B cells is linked to reduced survival following treatment.
Sbarrato T, Horvilleur E, Pöyry T, Hill K, Chaplin LC, Spriggs RV, Stoneley M, Wilson L, Jayne S, Vulliamy T, Beck D, Dokal I, Dyer MJ, Yeomans AM, Packham G, Bushell M, Wagner SD, Willis AE. Sbarrato T, et al. Among authors: yeomans am. Cell Death Dis. 2016 Jun 2;7(6):e2249. doi: 10.1038/cddis.2016.148. Cell Death Dis. 2016. PMID: 27253413 Free PMC article.
B-cell receptor signaling induces proteasomal degradation of PDCD4 via MEK1/2 and mTORC1 in malignant B cells.
Taylor J, Wilmore S, Marriot S, Rogers-Broadway KR, Fell R, Minton AR, Branch T, Ashton-Key M, Coldwell M, Stevenson FK, Forconi F, Steele AJ, Packham G, Yeomans A. Taylor J, et al. Among authors: yeomans a. Cell Signal. 2022 Jun;94:110311. doi: 10.1016/j.cellsig.2022.110311. Epub 2022 Mar 16. Cell Signal. 2022. PMID: 35306137 Free PMC article.
Azotemia in typhus fever.
YEOMANS A, SNYDER JC, et al. YEOMANS A, et al. Ann Intern Med. 1945 Nov;23:711-53. doi: 10.7326/0003-4819-23-5-711. Ann Intern Med. 1945. PMID: 21003581 No abstract available.
Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells.
Wilmore S, Rogers-Broadway KR, Taylor J, Lemm E, Fell R, Stevenson FK, Forconi F, Steele AJ, Coldwell M, Packham G, Yeomans A. Wilmore S, et al. Among authors: yeomans a. Cell Mol Life Sci. 2021 Sep;78(17-18):6337-6349. doi: 10.1007/s00018-021-03910-x. Epub 2021 Aug 16. Cell Mol Life Sci. 2021. PMID: 34398253 Free PMC article.
44 results